SLElupusSLE-DASanifrolumabBILAG-2004AstraZenecaEQ-5DSLEDAI-2KLupusQoLSLEDAI
…ifrolumab trials (MUSE, TULIP-1, TULIP-2) in moderate-to-severe SLE. Physicians’ assessments (clinical and laboratory data, BILAG-2…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Funders
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentions29,499matching articles
244,054matching entity mentions
30popular entities listed
0%of mentions human-reviewed
Popular entities in these results
Choose an entity to see the articles in which it was identified.
EMBASE784PUBMED717COVID-19645Cancer605SLE570Diabetes552NHS522WEB OF SCIENCE499Hypertension418SCOPUS417HIV406Systemic Lupus Erythematosus390Heart Failure364Asthma349Stroke336COPD331WHO330Colorectal Cancer327Cardiovascular Disease317Type 2 Diabetes316Chronic Obstructive Pulmonary Disease313Joanna Briggs Institute306MEDLINE306Atrial Fibrillation283Cochrane Library275Breast Cancer271Hepatocellular Carcinoma253SSc251Inflammatory Bowel Disease250Obesity246
Matching articles
29,499 articles · page 51 of 2459systemic sclerosissystemic lupus erythematosusSjögren’s diseaseSLEpAPSSScSjDPRECISESADS project
…pus erythematosus (SLE; n=249), Sjögren’s disease (SjD; n=253), systemic sclerosis (SSc; n=247), and from 497 matched healthy controls (HC) from t…
sitravatinibtislelizumabdocetaxel
…xel arm. Grade 5 haemoptysis occurred in 3 (1.6%) patients with sitravatinib plus tislelizumab. The study was terminated due to an unfavoura…
depressionchronic illnessAerobic exercise
…utcome was depressive symptoms and was assessed using validated depression rating scales.Results 36 randomised controlled trials involving…
adalimumabupadacitinibRAPsA
…-COMPARE, SELECT-PsA 1) assessed the effects of upadacitinib or adalimumab versus placebo on pain in patients with attenuation of inflamma…
scabiesivermectinpermethrin
…in cream, given on days 0 and 10, in achieving clinical cure of scabies on day 28 in index cases and their household members. Conversel…
rheumatoid arthritisRhAlactose intoleranceosteoporosis
…form a causal analysis of the link between lactose intolerance, rheumatoid arthritis (RhA) and body mass index (BMI). Lactose intolerance necessaril…
Transverse sinus stenosispulsatile tinnitusTSSPTsigmoid sinus wall anomaliesSSWAsidiopathic intracranial hypertension
…Background Transverse sinus stenosis (TSS) and sigmoid sinus wall anomalies (SSWAs) are the most com…
CRCulcerative colitiscolorectal cancerCrohn’s disease5-ASAsNon-sulfasalazine 5-ASAsIBD
…As) and immunomodulators with the risk of CRC and/or dysplasia (CRC/Dys) in different IBD phenotypes.Methods We searched Web of Sci…
muscle relaxantGabapentinopioidgabapentinoidTBIbenzodiazepineLBFtraumatic brain injury
…to 2022 (6.8% vs 19.3%; aRR 2.80 (95% CI 2.52 to 3.11)) whereas muscle relaxant use did not change (14.5% vs 13.5%; aRR 0.93 (95% CI 0.85 to 1.…
docetaxelNSCLCPlinabulinpembrolizumab
… B, Feinstein T, Shi Y, et al. Plinabulin plus docetaxel versus docetaxel in patients with non-small-cell lung cancer after disease progr…
solid tumorshematological malignanciesAC484ABBV-CLS-484
…d in the clinic to markedly enhance adoptive T cell therapy for solid tumors.Acknowledgments C.H.P., I.S., Y.L., M.N.P., and J.D.P. are empl…